vimarsana.com

Page 24 - Diffuse Largeb Cell Lymphoma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MorphoSys and Incyte Announce Five-Year Results of L-MIND Study Showed Prolonged, Durable Responses in Relapsed or Refractory DLBCL Patients Treated with Monjuvi® (tafasitamab-cxix)

TriNetX Publishes European Multiple Myeloma Real-World Evidence TherapyMonitor Report

Preexisting heart failure associated with lower use of anthracyclines and chemotherapy

1. In this longitudinal cohort study of 30 728 patients with diffuse large-B-cell lymphoma, preexisting heart failure at lymphoma diagnosis was present in 4266 patients and associated with lower anthracyclines use. 2. At one year, lymphoma mortality was 41.8% in patients with preexisting heart failure and 29.6% in patients without preexisting heart failure. Evidence Rating

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.